Christine L. Pasero

Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity

Christine L. Pasero, Gwénaëlle Gravis, Mathilde Guérin et al. · Cancer Research · 2016 · 210 citations

Immunology, Immune Regulation, Nk Cells +22

Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer

Christine L. Pasero, Gwénaëlle Gravis, Samuel Granjeaud et al. · Oncotarget · 2015 · 191 citations · Full text

Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response

Aude De Gassart, Kieu-Suong Le, Patrick Brune et al. · Science Translational Medicine · 2021 · 101 citations

Pain Ratings: The Fifth Vital Sign

Christine L. Pasero, Margo McCaffery · AJN American Journal of Nursing · 1997 · 96 citations

Nursing, Pain Therapy, Pain Syndrome +13

BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells

Carla E. Cano, Christine L. Pasero, Aude De Gassart et al. · Cell Reports · 2021 · 87 citations · Full text